Alexion Pharmaceuticals Inc. (ALXN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alexion Pharmaceuticals I...

    NASDAQ: ALXN · Real-Time Price · USD
    182.50
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Alexion Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2021
    Period Ending Mar 31, 2021
    Revenue
    		 1.64B
    Cost of Revenue
    		 125.4M
    Gross Profit
    		 1.51B
    Operating Income
    		 636.2M
    Interest Income
    		 n/a
    Pretax Income
    		 602.6M
    Net Income
    		 636M
    Selling & General & Admin
    		 342.9M
    Research & Development
    		 289.1M
    Other Expenses
    		 53.2M
    Operating Expenses
    		 685.2M
    Interest Expense
    		 27.1M
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 810.6M
    Income Tax Expense
    		 113.4M
    Shares Outstanding (Basic)
    		 220.1M
    Shares Outstanding (Diluted)
    		 222.6M
    EPS (Basic)
    		 2.89
    EPS (Diluted)
    		 2.86
    EBITDA
    		 852.1M
    EBIT
    		 629.7M
    Depreciation & Amortization
    		 75.6M

    Add to Watchlist